Bright Minds Biosciences Inc. (CSE:DRUG)
Canada · Delayed Price · Currency is CAD 95.10
-0.19 (-0.20%)
Jul 6, 2026, 10:48 AM EST
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of CAD 934.99 million as of July 6, 2026. Its market cap has increased by 151.87% in one year.
Market Cap
934.99M
Enterprise Value
625.38M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
95.10
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from 53.34M to 934.99M, an increase of 1,653.04%. That is a compound annual growth rate of 69.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 934.99M | 8.73% |
| Dec 31, 2025 | 859.94M | 138.45% |
| Dec 31, 2024 | 360.63M | 3,710.83% |
| Dec 29, 2023 | 9.46M | -50.41% |
| Dec 30, 2022 | 19.08M | -60.52% |
| Dec 31, 2021 | 48.34M | -9.37% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 622.57M |
| Satellos Bioscience | 227.27M |
| Helix BioPharma | 104.64M |
| Eastwood Bio-Medical Canada | 67.51M |
| ME Therapeutics Holdings | 59.80M |
| Telescope Innovations | 57.37M |
| NurExone Biologic | 51.18M |
| MedMira | 49.12M |